Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Revive Therapeutics Ltd (RVVTF)

Revive Therapeutics Ltd (RVVTF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade RVVTF with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3252 +3.94%
on 02/25/21
0.6000 -43.67%
on 02/16/21
-0.0974 (-22.37%)
since 02/03/21
3-Month
0.2060 +64.08%
on 12/04/20
0.7200 -53.06%
on 12/14/20
+0.1200 (+55.05%)
since 12/03/20
52-Week
0.0300 +1,026.67%
on 03/19/20
0.7200 -53.06%
on 12/14/20
+0.2980 (+745.00%)
since 03/03/20

Most Recent Stories

More News
Global Behavioral Health Market Where Psychedelics Have Shown Tremendous Potential Could Hit $240 Billion By 2026

, /PRNewswire/ -- Many people and investors may be confused, thinking that the Psychedelics market is part of the cannabis market. It is not a way to get higher 'highs' in the legal cannabis market…...

MCUR.CN : 0.495 (-2.94%)
CLXPF : 1.2262 (-2.29%)
MCURF : 0.3903 (-5.77%)
CMPS : 45.59 (-4.66%)
FTRP.CN : 6.980 (-1.97%)
FTRPF : 5.5500 (-2.81%)
RVV.CN : 0.420 (-9.68%)
RVVTF : 0.3360 (-9.16%)
PHRM.CN : 0.320 (unch)
PHRRF : 0.2400 (-5.88%)
Proactive news headlines including Mandalay Resources Corporation, Loop Insights, Nano One Materials and Delta 9 Cannabis

- Mandalay Resources Corporation (TSE:MND) (OTCQB:MNDJF) (FRA:R7X2) says 2020 results underline sustainability of its turnaround last year click here

N.VN : 0.325 (-2.99%)
MNDJF : 1.6700 (-2.33%)
N : 90.34 (unch)
NXTTF : 0.2593 (-3.07%)
VRNDF : 0.4180 (-5.00%)
MTRX : 14.19 (+2.60%)
RACMF : 1.0600 (-4.98%)
AAGFF : 0.8140 (-5.46%)
EDV.TO : 23.87 (-2.05%)
EDVMF : 18.6900 (-3.17%)
NC.CN : 0.910 (-8.08%)
NTTCF : 0.7144 (-5.98%)
NSP : 89.23 (-0.54%)
NSPDF : 0.0593 (-0.34%)
RVV.CN : 0.420 (-9.68%)
RVVTF : 0.3360 (-9.16%)
BYRN.CN : 1.800 (-4.26%)
BYRN : 1.4200 (-3.64%)
VLNCF : 1.3900 (-0.71%)
UPDATE -- Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19 with Planned Completion and Emergency Use Authorization Request

Revive Therapeutics Ltd. ("Revive" or the "Company") (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders,...

RVV.CN : 0.420 (-9.68%)
RVVTF : 0.3360 (-9.16%)
Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19 with Planned Completion and Emergency Use Authorization Request

Revive Therapeutics Ltd. ("Revive" or the "Company") (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders,...

RVV.CN : 0.420 (-9.68%)
RVVTF : 0.3360 (-9.16%)
First Movers in the Psychedelics Space Position Themselves as Industry Leaders

, /PRNewswire/ -- The emergence of psychedelics as a mental health solution and as a legitimate industry has been one of the most radical market developments that we have seen in decades. Far from being...

PULL.CN : 0.580 (+5.45%)
PRXTF : 0.4509 (+5.33%)
RVV.CN : 0.420 (-9.68%)
RVVTF : 0.3360 (-9.16%)
MYCO.CN : 0.455 (-4.21%)
MYCOF : 0.3578 (-5.47%)
AIKI : 1.1600 (-4.13%)
CMPS : 45.59 (-4.66%)
A Magical Era of Body/Mind Health and Wellness with Functional and Psychedelic Mushrooms

Point Roberts, Washington and Delta, British Columbia--(Newsfile Corp. - February 23, 2021) -  , a leading investor news resource on health and wellness stocks releases a sector snapshot looking at a...

RVVTF : 0.3360 (-9.16%)
LRSV : 0.0435 (-13.17%)
Ongoing Public Mental Health Crisis Calls For Innovative Treatments

, /PRNewswire/ -- The ongoing pandemic has inflamed and highlighted a separate but very connected public health crisis that has been growing all around the world for decades. Rates of mental health issues...

PULL.CN : 0.580 (+5.45%)
PRXTF : 0.4509 (+5.33%)
MYCO.CN : 0.455 (-4.21%)
MYCOF : 0.3578 (-5.47%)
RVV.CN : 0.420 (-9.68%)
RVVTF : 0.3360 (-9.16%)
TRYP.CN : 0.800 (-11.11%)
TRYPF : 0.6500 (-8.86%)
JNJ : 156.22 (-1.76%)
Revive Therapeutics Acquires Unique Psilocybin Assets

Revive Therapeutics Ltd. ("Revive" or the "Company") (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders,...

RVV.CN : 0.420 (-9.68%)
RVVTF : 0.3360 (-9.16%)
PHRM.CN : 0.320 (unch)
PHRRF : 0.2400 (-5.88%)
Revive Therapeutics Announces Closing of $23.0 Million Short Form Prospectus Offering

Revive Therapeutics Ltd. ("Revive" or the "Company") (CSE:RVV) (USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders,...

RVV.CN : 0.420 (-9.68%)
RVVTF : 0.3360 (-9.16%)
These are Some of the Top Cannabis Companies Generating Substantial Interest

There’s growing buzz with medical CBD, and the potential for further acquisitions. Just over ...

RVVTF : 0.3360 (-9.16%)
APHA : 18.18 (-4.06%)
APHA.TO : 23.01 (-3.80%)
WEED.TO : 42.06 (-5.42%)
CGC : 33.24 (-5.70%)
TLRY : 25.29 (-2.36%)
JUSHF : 7.4392 (-8.37%)
JUSH.CN : 9.480 (-7.51%)
RVV.CN : 0.420 (-9.68%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Key Turning Points

3rd Resistance Point 0.4303
2nd Resistance Point 0.4152
1st Resistance Point 0.3925
Last Price 0.3360
1st Support Level 0.3547
2nd Support Level 0.3396
3rd Support Level 0.3169

See More

52-Week High 0.7200
Fibonacci 61.8% 0.4564
Fibonacci 50% 0.3750
Last Price 0.3360
Fibonacci 38.2% 0.2936
52-Week Low 0.0300

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar